Guardant Health
GH
#981
Rank
โ‚น2.332 T
Marketcap
โ‚น17,384
Share price
2.54%
Change (1 day)
178.13%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น320.40

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น332.28. In 2025 the company made an earnings per share (EPS) of -โ‚น315.15 an increase over its 2024 EPS that were of -โ‚น338.95.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น320.401.67%
2025-โ‚น315.15-7.02%
2024-โ‚น338.95-16.82%
2023-โ‚น407.50-33.13%
2022-โ‚น609.3460%
2021-โ‚น380.8455.04%
2020-โ‚น245.64207.14%
2019-โ‚น79.98-19.81%
2018-โ‚น99.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น3.43-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น233.26-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA